6568
KNC Laboratories Co.,Ltd.
神戸天然物化学
- Industry
- Services
- Market
- Growth
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Non-consolidated
Key metrics
Revenue(thousand JPY)
Mar 2021
6,029,084
Mar 2022
7,440,588
Mar 2023
8,628,009
Mar 2024
9,154,577
Mar 2025
8,178,920
Operating profit(thousand JPY)
Mar 2021
635,468
Mar 2022
1,094,500
Mar 2023
2,163,738
Mar 2024
2,081,385
Mar 2025
771,859
Operating profit margin(%)
Mar 2021
10.54
Mar 2022
14.71
Mar 2023
25.08
Mar 2024
22.74
Mar 2025
9.44
Profit before tax(thousand JPY)
Mar 2021
585,978
Mar 2022
916,765
Mar 2023
2,172,363
Mar 2024
2,093,179
Mar 2025
927,993
Profit(thousand JPY)
Mar 2021
399,676
Mar 2022
643,463
Mar 2023
1,542,843
Mar 2024
1,493,023
Mar 2025
737,329
Total assets(thousand JPY)
Mar 2021
12,780,951
Mar 2022
13,951,586
Mar 2023
15,404,512
Mar 2024
18,621,632
Mar 2025
20,152,445
Cash and cash equivalents(thousand JPY)
Mar 2021
1,962,975
Mar 2022
1,973,588
Mar 2023
2,297,276
Mar 2024
3,311,547
Mar 2025
2,385,561
Cash flows from operating activities(thousand JPY)
Mar 2021
1,326,755
Mar 2022
585,109
Mar 2023
1,993,942
Mar 2024
3,204,538
Mar 2025
1,487,123
Cash flows from investing activities(thousand JPY)
Mar 2021
-660,047
Mar 2022
-613,514
Mar 2023
-1,146,863
Mar 2024
-2,369,133
Mar 2025
-3,322,708
Cash flows from financing activities(thousand JPY)
Mar 2021
-180,142
Mar 2022
39,017
Mar 2023
-523,391
Mar 2024
178,866
Mar 2025
909,599
Return on equity(%)
Mar 2021
4
Mar 2022
6.2
Mar 2023
13.8
Mar 2024
12
Mar 2025
5.5
Equity ratio(%)
Mar 2021
79.2
Mar 2022
75.8
Mar 2023
76.2
Mar 2024
70.3
Mar 2025
67.1
Earnings per share(JPY per share)
Mar 2021
51.54
Mar 2022
82.78
Mar 2023
200.06
Mar 2024
193.5
Mar 2025
95.42
Net assets per share(JPY per share)
Mar 2021
1,304.18
Mar 2022
1,359.28
Mar 2023
1,523.41
Mar 2024
1,695.35
Mar 2025
1,748.68
Dividend per share(JPY per share)
Mar 2021
25
Mar 2022
25
Mar 2023
28
Mar 2024
30
Mar 2025
33
Payout ratio(%)
Mar 2021
48.51
Mar 2022
30.2
Mar 2023
14
Mar 2024
15.5
Mar 2025
34.58
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.